Progress in EBV Vaccines

by Dwain G. van Zyl, Dwain G. van Zyl, Dwain G. van Zyl, Josef Mautner, Josef Mautner, Henri-Jacques Delecluse, Henri-Jacques Delecluse, Henri-Jacques Delecluse
Published 2019-02-01

Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice.

by Dwain G van Zyl, Ming-Han Tsai, Anatoliy Shumilov, Viktor Schneidt, Rémy Poirey, Bettina Schlehe, Herbert Fluhr, Josef Mautner, Henri-Jacques Delecluse
Published 2018-12-01